Ambeed.cn

首页 / 抑制剂/激动剂 / / VD/VDR / Alfacalcidol

阿法骨化醇 /Alfacalcidol {[allProObj[0].p_purity_real_show]}

货号:A462601 同义名: 1-hydroxycholecalciferol;1.alpha.-Hydroxyvitamin D3

Alfacalcidol是一种维生素 D3 的衍生物,非选择性地激活维生素 D 受体 (VDR) ,用于骨质疏松相关的研究。

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Alfacalcidol 化学结构 CAS号:41294-56-8
Alfacalcidol 化学结构
CAS号:41294-56-8
Alfacalcidol 3D分子结构
CAS号:41294-56-8
Alfacalcidol 化学结构 CAS号:41294-56-8
Alfacalcidol 3D分子结构 CAS号:41294-56-8
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Alfacalcidol 纯度/质量文件 产品仅供科研

货号:A462601 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

JMC, 2024. Ambeed. [ A919389 , A918471 , A995972 ]
Anal. Chem., 2024, 96(50): 19947-19954. Ambeed. [ A261947 , A1165388 ]
ACS Biomater. Sci. Eng., 2024. Ambeed. [ A220462 ]
ACS Biomater. Sci. Eng., 2024. Ambeed. [ A165235 , A110205 ]
Pharmaceutics, 2024, 16(12): 1546. Ambeed. [ A272538 , A187261 , A691302 , A506702 ]
更多 >

Alfacalcidol 生物活性

描述 Alfacalcidol is a non-selective VDR activator medication[3]. Alfacalcidol possesses immunoregulatory effects in vitro and in vivo by inhibiting the cytokines IL-1, IL-6, TNF-alpha and particularly IL-12. Therapy with alfacalcidol results in increased production of Th2 helper cells which produce bone protective cytokines like IL-4 and IL-10. Alfacalcidol retards corticosteroid-induced bone loss in contrast to plain vitamin D. Due to its immunomodulating properties, alfacalcidol is particularly suitable for RA(rheumatoid arthritis)-induced bone loss and for the prevention of transplantation osteoporosis, and an adjuvant contribution to the disease-modifying therapy of RA and to the immunosuppressive therapy after transplantation can not be excluded[4]. Alfacalcidol (0.025-0.1 mg/kg; p.o.; five times a week; for 3 months) exerts bone-protective effects independently of its Ca-related effects, and is in this respect superior to vitamin D(3), and that the skeletal actions of alfacalcidol take place, at least in part, independently of suppression of PTH(parathyroid hormone)[5].

Alfacalcidol 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT02069886 Thalassemia (Transfusion Delen... 展开 >>dent) 收起 << Phase 4 Withdrawn December 2018 -
NCT03483441 Basal Cell Nevus Syndrome ... 展开 >> Basal Cell Carcinoma 收起 << Phase 1 Recruiting May 1, 2023 United States, Arizona ... 展开 >> University of Arizona College of Medicine Not yet recruiting Phoenix, Arizona, United States, 85004 Contact: Nathalie Zeitouni, MD    602-406-8222    Nathalie.Zeitouni@dignityhealth.org    Sub-Investigator: Nathalie Zeitouni, MD          United States, Ohio Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Contact: Jeff Negrey, MA    216-636-5504    negreyj2@ccf.org    Principal Investigator: Edward Maytin, MD          Sub-Investigator: Christine Warren, MD 收起 <<
NCT02542865 Growth and Development Not Applicable Completed - India ... 展开 >> GSK Investigational Site Pune, India, 411001 收起 <<

Alfacalcidol 参考文献

[1]Ivarsen P, Povlsen JV, et al. Effect of alfacalcidol on cardiac function in patients with chronic kidney disease stage 4 and secondary hyperparathyroidism: a pilot study. Scand J Urol Nephrol. 2012 Oct;46(5):381-8.

[2]Ringe JD, Schacht E. Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol. Rheumatol Int. 2004 Jul;24(4):189-97. Epub 2004 Jun 30.

[3]Pavlovic D, Katicic D, Gulin T, Josipovic J. Vitamin d in the patients with chronic kidney disease: when, to whom and in which form. Mater Sociomed. 2015 Apr;27(2):122-4

[4]Schacht E. Osteoporose bei rheumatoider Arthritis--Bedeutung von Alfacalcidol in Prävention und Therapie [Osteoporosis in rheumatoid arthritis--significance of alfacalcidol in prevention and therapy]. Z Rheumatol. 2000;59 Suppl 1:10-20. German

[5]Shiraishi A, Higashi S, Ohkawa H, Kubodera N, Hirasawa T, Ezawa I, Ikeda K, Ogata E. The advantage of alfacalcidol over vitamin D in the treatment of osteoporosis. Calcif Tissue Int. 1999 Oct;65(4):311-6

Alfacalcidol 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.50mL

0.50mL

0.25mL

12.48mL

2.50mL

1.25mL

24.96mL

4.99mL

2.50mL

Alfacalcidol 技术信息

CAS号41294-56-8
分子式C27H44O2
分子量 400.637
别名 1-hydroxycholecalciferol;1.alpha.-Hydroxyvitamin D3;EB 644;alpha-Calcidol;Alpha D 3;Alfarol;Tevabone;Oxydevit;Etalpha;Bondiol;1-hydroxy Vitamin D3
运输蓝冰
存储条件

In solvent -20°C:3-6个月-80°C:12个月

Pure form Inert atmosphere,Store in freezer, under -20°C

溶解方案

DMSO: 50 mg/mL(124.8 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案一
方案二
动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。